Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Teva Pharmaceuticals is recalling 7,579 bottles of Methylphenidate Hydrochloride Extended-Release Capsules because routine stability testing revealed out-of-specification dissolution results.
Teva Pharmaceuticals is recalling 6,267 bottles of Terazosin Hydrochloride capsules because the 10 mg label contained 5 mg capsules.
Novartis is recalling 10.6 million Excedrin Migraine pouches because the packaging may not be fully sealed, potentially compromising product integrity.
Novartis is recalling Excedrin Extra Strength tablets in pouches that may not be fully sealed. The recall covers products distributed in the US, Puerto Rico, Brazil, and Panama.
West-Ward Pharmaceutical Corp. is recalling 51,704 bottles of Lisinopril Tablets, USP, 2.5 mg because they failed impurity specifications at the 48-month time point.
American Health Packaging is recalling Zolpidem Tartrate 5 mg tablets due to a packaging error that may result in blisters containing more than one tablet.
West-Ward Pharmaceutical Corp. is recalling 118 bottles of Ethambutol Hydrochloride Tablets 400 mg due to out-of-specification surface ink defects.
GlaxoSmithKline is recalling TUMS Ultra Assorted Berries 1000mg chewable tablets because they may contain foreign TUMS 750mg tablets.
Actavis Inc is recalling 15,132 bottles of BuPROPion Hydrochloride Extended-Release Tablets (XL) 300 mg because dissolution test results exceeded approved limits.
Novartis Consumer Health is recalling No Doz Max Strength caplets because the pouches may not be fully sealed.
Green Planet Inc is recalling Night Bullet Capsules because they contain unapproved active ingredients for erectile dysfunction.
Warner Chilcott US LLC is recalling 188,600 bottles of Enablex (darifenacin) 15 mg extended-release tablets because they failed impurity specifications.
Baxter Healthcare is recalling 39,486 containers of DIANEAL Low Calcium with Dextrose peritoneal dialysis solution because defective containers may leak when the closure is removed.
Torrent Pharma Inc is recalling 18,721 bottles of Olanzapine Tablets 10 mg because the packaging filler material was not approved.
Physicians Total Care is recalling Belladonna Alkaloids/PB tablets due to the presence of black spots on the tablets.
Actavis South Atlantic LLC is recalling 133,968 bottles of Ranitidine Syrup because the product failed an impurity specification for 'Related Compound C'.
Procter & Gamble is recalling 35,568 cartons of DayQuil and NyQuil Sinex liquicaps nationwide due to packaging defects that may cause missing or misplaced capsules.
Med Prep Consulting is recalling 403,883 bags of Magnesium Sulfate 2 grams in Dextrose 5% for Injection due to non-sterility and mold contamination.
West-Ward Pharmaceutical Corp. is recalling Belladonna Alkaloids with Phenobarbital Tablets because they contain a trace amount of Methocarbamol.
Hospira is recalling 268,700 vials of Sodium Chloride Injection, USP, 0.9% due to a confirmed report of visible particulate matter embedded in the plastic vial.
Med Prep Consulting, Inc. is recalling all compounded products due to a lack of assurance of sterility and potential mold contamination.
Mobius Therapeutics is recalling 83 boxes of Mitosol ophthalmic kits because components were found to be contaminated with yeast.
Astellas Pharma US is voluntarily recalling specific lots of AmBisome (amphotericin B) liposome for injection because a routine simulation detected bacterial contamination.
Gilead Sciences is recalling 478,352 vials of AmBisome (amphotericin B) liposome for Injection due to a lack of sterility assurance detected during routine manufacturing simulations.
Alkermes, Inc. is recalling 3,325 vials of VIVITROL (naltrexone) because the product failed container closure integrity testing, raising concerns about sterility.